Monday, 31 August 2026European Markets

GC RIEBER SHIPPING Stock Was 12.89% Up On Thursday

Loading stream...

(VIANEWS) - The Market ended the session with GC RIEBER SHIPPING (RISH.OL) rising 12.89% to kr21.90 on Thursday, after three consecutive sessions in a row of gains. Oslo Børs Benchmark Index_GI jumped 1.11% to kr1,223.29, after two sequential sessions in a row of gains, on what was an all-around bullish trend exchanging session today.

GC RIEBER SHIPPING's last close was kr19.40, 0.26% higher than its 52-week high of kr19.35.

About GC RIEBER SHIPPING

GC Rieber Shipping ASA operates as a ship-owning project house with a focus on developing maritime projects in Norway and internationally. The company was incorporated in 2005 and is headquartered in Bergen, Norway. GC Rieber Shipping ASA is a subsidiary of GC Rieber AS.

Earnings Per Share

As for profitability, GC RIEBER SHIPPING has a trailing twelve months EPS of kr-0.43.

The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is negative -2.94%.

Moving Average

GC RIEBER SHIPPING's worth is way above its 50-day moving average of kr16.33 and way higher than its 200-day moving average of kr13.19.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, GC RIEBER SHIPPING's stock is considered to be oversold (<=20).

More news about GC RIEBER SHIPPING (RISH.OL).

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Hawkish Fed Signals at Jackson Hole Pressure Rate-Sensitive Assets
Kevin Warsh's hawkish inflation remarks at Jackson Hole, alongside a steady drumbeat of Federal Reserve testimony from Powell, Barr, Bowman and other officials on supervision, regulation and monetary policy, signal continued vigilance against inflation rather than an imminent easing cycle. Rate-sensitive and precious-metals-linked names such as SSR Mining sold off the same day, consistent with markets repricing for a firmer-for-longer policy stance.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
We flag conflicts openly ›
Recently verified
Checked against the original source
4,979
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,979 facts checked against source5,261 source documents archived
Query this data → isubstrate.com